Host DNA depletion at the wet laboratory stage has emerged as a highly effective strategy for enhancing microorganism detection in metagenomic workflows.
Molzym’s MolYsis™ technology enables clinical laboratories to deplete host DNA and enrich microbial DNA, leading to faster and more accurate pathogen detection and improved patient outcomes.
Distributed in the UK and Ireland by VH Bio, this technology was embraced by ELDA Biotech to develop a clinical testing workflow for Enfer Medical in Ireland.
Download our white paper to learn about:
- An overview of MolYsis™ technology and the SelectNA™plus instrument
- How Enfer Medical set a new standard in clinical diagnostics using SelectNA™plus
- The role of SelectNA™plus in the clinical space, including future perspectives
- Validation, accreditation, and implementation considerations
- Measurable impact on laboratory efficiency and clinical outcomes
Please fill in the form to receive a copy of the white paper via email.
